FINANCIALS

ACAD Acadia Pharmaceuticals Inc 1070494

Income Statement
Revenue	acad-20240930	250,401,000
Net Income	acad-20240930	32,765,000
Profit Margin		13.09%

Balance Sheet
Current Assets	788,284,000
Assets	976,868,000
Current Liabilities	343,945,000
Liabilities	399,688,000
Equity	577,180,000
Shares Out	165,876,000

Cash Flow Statement
Operating Cash Flow	117,338,000
Investing Cash Flow	-152,688,000

Market Analysis
Market Cap	2,688,849,808
BVPS	3.48
PB	5.04
EPS	0.18
PE	89.40
PS	2.68
FCF	-35,350,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view ACAD documents filed with the SEC.

ACAD Filings Clear

View A List of Tickers